CRTAM Antikörper (AA 31-130) (FITC)
-
- Target Alle CRTAM Antikörper anzeigen
- CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))
-
Bindungsspezifität
- AA 31-130
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CRTAM Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Maus
- Homologie
- Rat,Pig,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human CRTAM
- Isotyp
- IgG
- Top Product
- Discover our top product CRTAM Primärantikörper
-
-
- Applikationshinweise
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- CRTAM (Cytotoxic and Regulatory T Cell Molecule (CRTAM))
- Andere Bezeichnung
- CRTAM (CRTAM Produkte)
- Synonyme
- TAD antikoerper, cTADS antikoerper, MGC82176 antikoerper, CRTAM antikoerper, CD355 antikoerper, cytotoxic and regulatory T-cell molecule antikoerper, cytotoxic and regulatory T-cell molecule L homeolog antikoerper, cytotoxic and regulatory T cell molecule antikoerper, CRTAM antikoerper, crtam.L antikoerper, Crtam antikoerper
- Hintergrund
-
Synonyms: CD355, Cytotoxic and regulatory T-cell molecule, Class-I MHC-restricted T-cell-associated molecule, CRTAM
Background: Interaction with CADM1 promotes natural killer (NK) cell cytotoxicity and interferon-gamma (IFN-gamma) secretion by CD8+ cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM3 in vivo.
- Gen-ID
- 56253
- UniProt
- O95727
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation
-